english.prescrire.org > Prescrire International > N°180 - March 2017

n°180

March 2017

Issue Contents
Editorial

Free  Brexit

p.59

New Products


Secukinumab (Cosentyx°) and plaque psoriasis

p.61-62
An alternative to TNF-alpha antagonists for patients with severe skin lesions

Secukinumab and ankylosing arthritis

p.62

Secukinumab and psoriatic arthritis

p.62

Tedizolid (Sivextro°) in skin and soft tissue infections

p.63-64
A me-too of linezolid

Capsaicin (Qutenza°) and diabetic neuropathic pain

p.65-66
Harmful, and no tangible efficacy

INN Common stem: -dronic

p.66

Adverse Effects


Drug-induced diarrhoea

p.67-71

Pegloticase: withdrawal of its European marketing authorisation is welcome

p.71

Reviews


Graves' disease in adults

p.72-77
Antithyroid drugs, radioactive iodine, or sometimes thyroidectomy

Osteoarthritis of the knee

p.78
Hyaluronic acid, a drug to avoid

Outlook


Free  2016 Prescrire Drug Awards

p.79-80

Free  The Prescrire Awards for 2016

p.79-83

Free  2016 Prescrire Packaging Awards

p.81-82

Free  2016 Prescrire Information Awards

p.83

Masthead


Free  Masthead

p.58

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe